Enterprise Financial Services Corp (EFSC)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-245	Closed	-$1K	–	1080
2016 Q1	$1K	Buy	+245	New	+$978	﹤0.01%	1026
2015 Q4	–	Sell	-13	Closed	–	–	1183
2015 Q3	$0	Hold	13	–	–	﹤0.01%	1178
2015 Q2	$0	Hold	13	–	–	﹤0.01%	1269
2015 Q1	$0	Sell	13 -88	-87%	-$1.13K	﹤0.01%	1340
2014 Q4	$1K	Hold	101	–	–	﹤0.01%	1250
2014 Q3	$1K	Buy	+101	New	+$1.55K	﹤0.01%	1222
2014 Q2	–	Sell	-143	Closed	-$2K	–	1351
2014 Q1	$2K	Buy	+143	New	+$2.16K	﹤0.01%	1111

Other funds holding KERX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s KERX Position: Q2 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2016, closing a stake of 245 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in KERX in Q1 2014 and held it in 7 quarters. The position peaked at $2K in Q1 2014. 118 funds tracked by Wall St. Rank hold KERX as of Q2 2016.

Enterprise Financial Services Corp (EFSC) reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 245 Keryx Biopharmaceuticals Inc shares in Q2 2016, an estimated $1K.
Enterprise Financial Services Corp (EFSC) first reported a position in Keryx Biopharmaceuticals Inc in Q1 2014 and held it in 7 quarters.
Enterprise Financial Services Corp (EFSC)'s Keryx Biopharmaceuticals Inc position peaked at $2K in Q1 2014.
118 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q2 2016, filed 29 Jul 2016.